Insider Selling: Heartflow (NASDAQ:HTFL) CFO Sells $190,649.05 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 3,587 shares of the firm’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $53.15, for a total value of $190,649.05. Following the transaction, the chief financial officer directly owned 149,587 shares in the company, valued at approximately $7,950,549.05. This represents a 2.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Vikram Verghese also recently made the following trade(s):

• On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The shares were sold at an average price of $50.75, for a total value of $850,874.50.
• On Thursday, September 17th, Vikram Verghese sold 7,579 shares of Heartflow stock. The shares were sold at an average price of $50.11, for a total value of $379,783.69.
• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total value of $33,406.68.
• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total value of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total value of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total value of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Down 1.5%

Shares of NASDAQ HTFL traded down $0.86 during mid-day trading on Tuesday, hitting $55.80. 1,276,518 shares of the company were exchanged, compared to its average volume of 1,595,194. The stock has a 50 day simple moving average of $51.45 and a 200-day simple moving average of $34.75. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $60.56. The firm has a market cap of $4.85 billion, a price-to-earnings ratio of -30.49 and a beta of 2.50.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company’s revenue for the quarter was up 47.7% on a year-over-year basis. Analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HTFL. Stifel Nicolaus lifted their target price on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Heartflow in a research note on Wednesday, November 4th. Wells Fargo & Company increased their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Finally, Canaccord Genuity Group raised their price objective on shares of Heartflow from $45.00 to $56.00 and gave the company a “buy” rating in a research report on Tuesday, September 22nd. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Heartflow presently has a consensus rating of “Moderate Buy” and a consensus price target of $48.62.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. XXEC Inc. acquired a new stake in Heartflow in the second quarter valued at $2,524,764,000. BlackRock Inc. acquired a new position in shares of Heartflow during the 2nd quarter worth $152,502,000. Bamco Inc. NY acquired a new position in shares of Heartflow during the 2nd quarter worth $94,625,000. Jupiter Topco LLC purchased a new position in shares of Heartflow in the 2nd quarter valued at about $70,983,000. Finally, Janus Henderson Group PLC increased its holdings in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.